Beta Bionics CEO Saint Sean sold 5,641 shares at $20.08 per share on September 3, leaving 398,429 shares after the transaction. The disclosed post-sale holding gives investors a direct view of the president and CEO’s remaining stake in Beta Bionics following the executive share sale.
Key Highlights
- The transaction was dated September 3, 2026.
- Saint Sean was identified as Beta Bionics’ President and CEO.
- His reported ownership after the sale stood at 398,429 shares.
Beta Bionics, Inc. (NASDAQ: BBNX) President and CEO Saint Sean sold 5,641 shares at $20.08 per share. The transaction was dated September 3, 2026, and the disclosed post-sale holding was 398,429 shares.
Beta Bionics CEO’s Remaining Stake
The sale price applied to each of the 5,641 shares transferred. The company’s reported transaction date was September 3, 2026. After the sale, Saint Sean held 398,429 shares of Beta Bionics.
FAQs
Q: How many Beta Bionics shares did Saint Sean sell?
A: President and CEO Saint Sean sold 5,641 Beta Bionics shares at $20.08 per share on September 3, 2026. His reported ownership afterward was 398,429 shares.
Q: What was the price of Saint Sean’s BBNX share sale?
A: The Beta Bionics executive transaction was priced at $20.08 per share. The sale involved 5,641 shares and was dated September 3, 2026.
Q: How many shares did the Beta Bionics CEO retain?
A: Saint Sean’s disclosed post-transaction ownership was 398,429 Beta Bionics shares. He was identified as the company’s President and CEO in the transaction details.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.